BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25408438)

  • 1. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience.
    Sago H; Sekizawa A;
    Prenat Diagn; 2015 Apr; 35(4):331-6. PubMed ID: 25408438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
    Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
    Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of non-invasive prenatal testing in Japan.
    Samura O; Sekizawa A; Suzumori N; Sasaki A; Wada S; Hamanoue H; Hirahara F; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Nakayama S; Okai T; Kamei Y; Namba A; Murotsuki J; Tanemoto T; Fukushima A; Haino K; Tairaku S; Matsubara K; Maeda K; Kaji T; Ogawa M; Osada H; Nishizawa H; Okamoto Y; Kanagawa T; Kakigano A; Kitagawa M; Ogawa M; Izumi S; Katagiri Y; Takeshita N; Kasai Y; Naruse K; Neki R; Masuyama H; Hyodo M; Kawano Y; Ohba T; Ichizuka K; Kido Y; Fukao T; Miharu N; Nagamatsu T; Watanabe A; Hamajima N; Hirose M; Sanui A; Shirato N; Yotsumoto J; Nishiyama M; Hirose T; Sago H
    J Obstet Gynaecol Res; 2017 Aug; 43(8):1245-1255. PubMed ID: 28586143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open source non-invasive prenatal testing platform and its performance in a public health laboratory.
    Johansen P; Richter SR; Balslev-Harder M; Miltoft CB; Tabor A; Duno M; Kjaergaard S
    Prenat Diagn; 2016 Jun; 36(6):530-6. PubMed ID: 27027563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.
    Lau TK; Jiang FM; Stevenson RJ; Lo TK; Chan LW; Chan MK; Lo PS; Wang W; Zhang HY; Chen F; Choy KW
    Prenat Diagn; 2013 Jun; 33(6):602-8. PubMed ID: 23553438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.
    Lau TK; Chen F; Pan X; Pooh RK; Jiang F; Li Y; Jiang H; Li X; Chen S; Zhang X
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1370-4. PubMed ID: 22070770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors.
    Dan S; Wang W; Ren J; Li Y; Hu H; Xu Z; Lau TK; Xie J; Zhao W; Huang H; Xie J; Sun L; Zhang X; Wang W; Liao S; Qiang R; Cao J; Zhang Q; Zhou Y; Zhu H; Zhong M; Guo Y; Lin L; Gao Z; Yao H; Zhang H; Zhao L; Jiang F; Chen F; Jiang H; Li S; Li Y; Wang J; Wang J; Duan T; Su Y; Zhang X
    Prenat Diagn; 2012 Dec; 32(13):1225-32. PubMed ID: 23138752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.
    Bianchi DW; Platt LD; Goldberg JD; Abuhamad AZ; Sehnert AJ; Rava RP;
    Obstet Gynecol; 2012 May; 119(5):890-901. PubMed ID: 22362253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum--preliminary results].
    Bijok J; Gorzelnik K; Massalska D; Ilnicka A; Pawłowska B; Zimowski JG; Kucińska-Chahwan A; Jakiel G; Roszkowski T
    Ginekol Pol; 2014 Mar; 85(3):208-13. PubMed ID: 24783433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
    Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
    Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of maternal copy number variations to false-positive fetal trisomies detected by noninvasive prenatal testing.
    Zhou X; Sui L; Xu Y; Song Y; Qi Q; Zhang J; Zhu H; Sun H; Tian F; Xu M; Cram DS; Liu J
    Prenat Diagn; 2017 Apr; 37(4):318-322. PubMed ID: 28152582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing.
    Liang D; Lv W; Wang H; Xu L; Liu J; Li H; Hu L; Peng Y; Wu L
    Prenat Diagn; 2013 May; 33(5):409-15. PubMed ID: 23299662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray-based cell-free DNA analysis improves noninvasive prenatal testing.
    Juneau K; Bogard PE; Huang S; Mohseni M; Wang ET; Ryvkin P; Kingsley C; Struble CA; Oliphant A; Zahn JM
    Fetal Diagn Ther; 2014; 36(4):282-6. PubMed ID: 25228026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Result of prenatal diagnosis for 151 high-risk women by noninvasive prenatal screening based on high-throughput sequencing].
    Jia Y; Zhang Y; Hao W; Shi D; Meng J; Zhao H; Lian Y; Xie L; Wang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct; 34(5):759-763. PubMed ID: 28981949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
    Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.
    Canick JA; Palomaki GE; Kloza EM; Lambert-Messerlian GM; Haddow JE
    Prenat Diagn; 2013 Jul; 33(7):667-74. PubMed ID: 23592541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood.
    Fan HC; Blumenfeld YJ; Chitkara U; Hudgins L; Quake SR
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16266-71. PubMed ID: 18838674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.